Literature DB >> 24837201

Role of neutrophil extracellular traps following injury.

Fu-Chao Liu1, Yueh-Hsun Chuang, Yung-Fong Tsai, Huang-Ping Yu.   

Abstract

Neutrophil extracellular traps (NETs), which consist of neutrophil DNA and cytoplasmic proteins, have been shown to be involved in various infectious, inflammatory, and autoimmune diseases. Neutrophil extracellular traps are abundant at the site of infection and acute inflammation. Neutrophil extracellular trap formation can occur through various intracellular signaling pathways, including peptidylarginine deiminase 4, Raf-MEK-ERK, nitric oxide, Toll-like receptor 4, high mobility group box 1, pentraxin 3, and mammalian targets of rapamycin. A growing body of evidence indicates that NETs may play an important role in injury, and decreases in NETs could reduce tissue injury. Neutrophil extracellular traps are believed to modulate the inflammatory and immune responses of individuals after injury. In this review, the role of NETs in injury, including traumatic injury, ischemia-reperfusion-induced injury, and sepsis, as well as the potential markers and therapeutic targets of NET-related injury will be discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24837201     DOI: 10.1097/SHK.0000000000000146

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  34 in total

Review 1.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

2.  Deoxyribonuclease Reduces Tissue Injury and Improves Survival After Hemorrhagic Shock.

Authors:  Joaquin Cagliani; Weng-Lang Yang; Max Brenner; Ping Wang
Journal:  J Surg Res       Date:  2020-01-08       Impact factor: 2.192

3.  SPRED2 deficiency may lead to lung ischemia-reperfusion injury via ERK1/2 signaling pathway activation.

Authors:  Masanori Okada; Masaomi Yamane; Sumiharu Yamamoto; Shinji Otani; Kentaroh Miyoshi; Seiichiro Sugimoto; Akihiro Matsukawa; Shinichi Toyooka; Takahiro Oto; Shinichiro Miyoshi
Journal:  Surg Today       Date:  2018-07-18       Impact factor: 2.549

4.  The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.

Authors:  Katarzyna Pawlik; Anna Piotrowska; Klaudia Kwiatkowski; Katarzyna Ciapała; Katarzyna Popiolek-Barczyk; Wioletta Makuch; Joanna Mika
Journal:  Immunology       Date:  2020-02-05       Impact factor: 7.397

5.  Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.

Authors:  Sergio Duarte; Patrick Matian; Stacy Ma; Ronald W Busuttil; Ana J Coito
Journal:  Am J Pathol       Date:  2018-06-02       Impact factor: 4.307

6.  Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury.

Authors:  Wesley M Raup-Konsavage; Yanming Wang; Wei Wei Wang; Denis Feliers; Hong Ruan; W Brian Reeves
Journal:  Kidney Int       Date:  2017-10-20       Impact factor: 10.612

Review 7.  The Role of Neutrophils in Transplanted Organs.

Authors:  Davide Scozzi; Mohsen Ibrahim; Cecilia Menna; Alexander S Krupnick; Daniel Kreisel; Andrew E Gelman
Journal:  Am J Transplant       Date:  2016-07-25       Impact factor: 8.086

Review 8.  Consequences of extracellular trap formation in sepsis.

Authors:  Xian M O'Brien; Bethany M Biron; Jonathan S Reichner
Journal:  Curr Opin Hematol       Date:  2017-01       Impact factor: 3.284

9.  Hemodynamic force triggers rapid NETosis within sterile thrombotic occlusions.

Authors:  X Yu; J Tan; S L Diamond
Journal:  J Thromb Haemost       Date:  2018-01-12       Impact factor: 5.824

10.  Effect of DNase I treatment and neutrophil depletion on acute limb ischemia-reperfusion injury in mice.

Authors:  Hassan Albadawi; Rahmi Oklu; Rita Elise Raacke Malley; Ryan M O'Keefe; Thuy P Uong; Nicholas R Cormier; Michael T Watkins
Journal:  J Vasc Surg       Date:  2015-12-15       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.